Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Proximal Ventures raises $27.5m fund for AI in drug development

A new venture capital fund, Proximal Ventures, has secured $27.5 million to invest in startups applying artificial intelligence to drug development.

  • Proximal Ventures, led by Sahir Raoof, has raised $27.5 million for its first fund.
  • The fund aims to back pre-seed and seed-stage startups using AI to transform drug development services.
  • Proximal Ventures has already invested in seven startups, including ChronicleBio.

Proximal Ventures, a new venture capital firm, has successfully raised $27.5 million for its debut fund. The fund, led by former SignalFire investor Sahir Raoof, will focus on investing in startups that integrate artificial intelligence (AI) into drug development processes.

The firm plans to support pre-seed and seed-stage companies, with investments ranging from $500,000 to $1.5 million. Raoof believes AI can automate various stages of drug development, potentially reducing costs and time for pharmaceutical services.

Proximal Ventures has already backed seven startups. One such investment is ChronicleBio, co-founded by former OpenAI executive Fidji Simo, which uses AI to analyse biological and medical data to understand chronic diseases and identify potential treatments.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.